NLTX - Neurogene Inc.

QQQ $ 479.98 $ -2.50 (-0.52 %)

DIA $ 391.11 $ -0.43 (-0.11 %)

SPY $ 544.70 $ -2.15 (-0.39 %)

TLT $ 91.77 $ -1.74 (-1.86 %)

GLD $ 215.03 $ 0.02 (0.01 %)

Previous Close

$ 36.39

Open

$ 34.67

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 34.15 - $ 37.01

52 Week Range

$ 12.49 - $ 53.00

Volume

1,545,882

Average Volume

Market Cap

9.69M

Beta (5Y Monthly)

$ 4.71

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-10-2024	03-31-2024	10-Q
2	03-18-2024	12-31-2023	10-K
3	11-14-2023	09-30-2023	10-Q
4	08-10-2023	06-30-2023	10-Q
5	05-08-2023	03-31-2023	10-Q
6	03-20-2023	12-31-2022	10-K
7	11-14-2022	09-30-2022	10-Q
8	08-09-2022	06-30-2022	10-Q
9	05-09-2022	03-31-2022	10-Q
10	03-01-2022	12-31-2021	10-K
11	11-04-2021	09-30-2021	10-Q
12	08-05-2021	06-30-2021	10-Q
13	05-12-2021	03-31-2021	10-Q
14	03-25-2021	12-31-2020	10-K
15	11-09-2020	09-30-2020	10-Q
16	08-12-2020	06-30-2020	10-Q
17	05-06-2020	03-31-2020	10-Q
18	03-12-2020	12-31-2019	10-K
19	11-13-2019	09-30-2019	10-Q
20	08-01-2019	06-30-2019	10-Q
21	05-07-2019	03-31-2019	10-Q
22	03-07-2019	12-31-2018	10-K
23	11-07-2018	09-30-2018	10-Q
24	08-08-2018	06-30-2018	10-Q
25	05-08-2018	03-31-2018	10-Q
26	03-12-2018	12-31-2017	10-K
27	11-08-2017	09-30-2017	10-Q
28	08-08-2017	06-30-2017	10-Q
29	05-09-2017	03-31-2017	10-Q
30	03-09-2017	12-31-2016	10-K
31	11-09-2016	09-30-2016	10-Q
32	08-04-2016	06-30-2016	10-Q
33	05-10-2016	03-31-2016	10-Q
34	03-14-2016	12-31-2015	10-K
35	11-10-2015	09-30-2015	10-Q
36	08-06-2015	06-30-2015	10-Q
37	05-12-2015	03-31-2015	10-Q
38	03-16-2015	12-31-2014	10-K
39	11-04-2014	09-30-2014	10-Q
40	08-11-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

BMO Capital Initiates Coverage On Neurogen...
06/27/2024 09:17:12

BMO Capital analyst Keith Tapper initiates coverage on Neurogene (NASDAQ:NGNE) with a Outperform rating and announces Price ...

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
06/20/2024 12:05:58

HC Wainwright & Co. Reiterates Buy on Neur...
06/20/2024 10:36:34

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Neurogene (NASDAQ:NGNE) with a Buy and maintains $51 price target.

why-quantum-shares-are-trading-lower-by-45-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Quantum Shares Are Trading Lower By 45...
06/18/2024 17:39:53

Neurogene Reports First Patient Dosed In H...
06/18/2024 13:28:02

High-dose NGN-401 has been well-tolerated, and low-dose NGN-401 continues to show a favorable safety profileInterim safety data...

Baird Initiates Coverage On Neurogene with...
06/11/2024 09:18:01

Baird analyst Joel Beatty initiates coverage on Neurogene (NASDAQ:NGNE) with a Outperform rating and announces Price Target ...

HC Wainwright & Co. Reiterates Buy on Neur...
06/04/2024 10:38:09

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Neurogene (NASDAQ:NGNE) with a Buy and maintains $51 price target.

Neurogene Says NGN-401 Gene Therapy For Re...
06/03/2024 11:45:49

As part of the START Program, Neurogene will have opportunities for enhanced communications with the FDA, with the aim to furth...

HC Wainwright & Co. Maintains Buy on Neuro...
05/13/2024 14:56:51

HC Wainwright & Co. analyst Mitchell Kapoor maintains Neurogene (NASDAQ:NGNE) with a Buy and lowers the price target fro...

Neurogene Q1 EPS $(1.00) Misses $(1.14) Es...
05/10/2024 11:36:13

Neurogene (NASDAQ:NGNE) reported quarterly losses of $(1.00) per share which beat the analyst consensus estimate of $(1.14) by ...

HC Wainwright & Co. Reiterates Buy on Neur...
05/08/2024 13:28:41

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Neurogene (NASDAQ:NGNE) with a Buy and maintains $55 price target.

Neurogene Announced Initial Safety And Tol...
05/07/2024 10:21:11

These data were presented during the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting.

HC Wainwright & Co. Reiterates Buy on Neur...
05/03/2024 20:11:23

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Neurogene (NASDAQ:NGNE) with a Buy and maintains $55 price target.

Leerink Partners Initiates Coverage On Neu...
04/29/2024 12:45:24

Leerink Partners analyst Mani Foroohar initiates coverage on Neurogene (NASDAQ:NGNE) with a Outperform rating and announces ...

Neurogene Reports Upcoming Presentation Of...
04/22/2024 20:38:00

The data show that the NGN-401 gene therapy candidate has been generally well-tolerated, and there have been no treatment-emerg...

William Blair Initiates Coverage On Neurog...
03/21/2024 10:06:07

William Blair analyst Sami Corwin initiates coverage on Neurogene (NASDAQ:NGNE) with a Outperform rating.

HC Wainwright & Co. Maintains Buy on Neuro...
03/19/2024 10:34:49

HC Wainwright & Co. analyst Mitchell Kapoor maintains Neurogene (NASDAQ:NGNE) with a Buy and raises the price target fro...

HC Wainwright & Co. Reiterates Buy on Neur...
03/05/2024 11:38:50

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Neurogene (NASDAQ:NGNE) with a Buy and maintains $45 price target.

Neurogene Announces Expansion and Plans fo...
03/04/2024 12:32:15

Neurogene Inc. (NASDAQ:NGNE) ("Neurogene" or "the Company"), a clinical-stage company founded to bring life-cha...

HC Wainwright & Co. Reiterates Buy on Neur...
01/17/2024 11:48:41

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Neurogene (NASDAQ:NGNE) with a Buy and maintains $45 price target.

CLASS ACTION DEADLINES - JOIN NOW!

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)

07/01/2024 Equinix, Inc. (EQIX)

07/02/2024 Intel Corporation (INTC)

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/15/2024 UnitedHealth Group Inc. (UNH)

07/16/2024 Teladoc Health, Inc. (TDOC)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)

NGNENeurogene Inc.

Nasdaq neoleukin.com

$ 36.35 $ 1.57 (4.51 %)

Friday, 28-Jun-2024 15:59:48 EDT